Canada: Parliamentary Committee Issues IP-Based Recommendations To Promote Innovation

Last Updated: April 10 2013
Article by Kiernan A. Murphy

Most Read Contributor in Canada, October 2018

On March 18, 2013, the Canadian Parliament’s Standing Committee on Industry, Science and Technology (referred to as “INDU”) published a report titled “Intellectual Property Regime in Canada” (the “Report”). INDU, which is composed of twelve members of Parliament, was mandated in the spring of 2012 to study the intellectual property (“IP”) regime in Canada and how this regime contributes to advancing innovation.

After hearing from approximately fifty witnesses, INDU issued in the Report several recommendations to the Government of Canada relating to Canada’s IP regime. Many of these recommendations seek to encourage the government to undertake further study of aspects of Canada’s IP regime and promote awareness of this regime. INDU also issued specific recommendations, some of which are summarized below (as categorized in the Report).

Specific Challenges Facing the Canadian Pharmaceutical Industry

INDU recommended that Canada ensure the pharmaceutical IP regime strike a balance between encouraging investment in the development of new and innovative drugs while ensuring Canadians have access to affordable pharmaceuticals. More specifically, INDU recommended that Canada undertake an independent, evidence-based review of challenges facing the brand-name pharmaceutical sector in Canada to determine appropriate next steps.

INDU’s high-level recommendations appear to reflect the diverging views of witnesses regarding the pharmaceutical IP regime. For example, the witnesses disagreed about Canada’s negotiations with the European Union for the Comprehensive Economic and Trade Agreement. Members of the innovative pharmaceutical industry noted that CETA presents Canada with a unique opportunity to make necessary improvements to harmonize Canada’s life sciences IP regime with Europe and, in so doing, become the only country in the world with favoured trade status with both the USA and the EU. Specific improvements sought by pharmaceutical innovators include an effective right of appeal in invalidity proceedings, an extension of data protection regulations from 8 years to 10 years, and the availability of patent term restoration. In contrast, the generic pharmaceutical industry opposes the EU’s demands for increased IP protection.

Canadian Intellectual Property Office and Government of Canada Policy and Programs

INDU specifically recommended that Canada ratify key international IP agreements, namely the Patent Law Treaty, the Madrid Protocol for the International Registration of Marks, the Singapore Treaty on the Law of Trade-marks, and the Hague Agreement Concerning the International Deposit of Industrial Designs. In the Report, INDU noted that there is a very strong consensus among witnesses consulted that better collaboration and improved harmonization internationally with respect to IP protection is needed.

INDU also recommended that Canada develop consistent IP policies for the aerospace industry across all government departments, make policies relating to foreign collaboration more flexible, and strengthen procurement policies by negotiating IP rights when purchasing foreign aircrafts.

Streamlining the Intellectual Property Process

As part of a review of domestic and international patent frameworks, INDU recommended that Canada identify ways to strengthen patent quality, enhance patent disclosure, and improve the efficiency of the system for enforcing patent rights. In addition, INDU recommended that Canada work with the Canadian Intellectual Property Office (“CIPO”) to introduce regulations and legislation that will reduce the time it takes to grant IP rights and bring Canada in line with other countries. In the Report, INDU noted the witnesses’ concerns regarding the high cost of obtaining and defending patents. Some solutions discussed (though INDU issued no recommendations in this regard) include: the Patent Prosecution Highway, terminal disclaimers and short deferral periods; a Canadian version of the U.S. provisional patent application; specialized IP courts or non-judicial administrative procedures; and, increased online accessibility and searchability of CIPO’s database.

INDU also recommended that Canada should only consider expanding patentability to new subject matter when there is clear and demonstrable benefit to Canadians and competition. In this regard, the Report acknowledged the debate regarding whether business methods and software ought to be patentable.

One witness suggested that Canada consider adopting legislation preventing “patent trolls” (a.k.a. non-practicing entities or patent assertion entities) from obtaining court injunctions. The same witness also noted that, as patent trolls have to date not been particularly active in Canada, the issue was not an urgent one. INDU made no specific recommendations in this regard.

Piracy / Counterfeit / Trade-marks / Copyrights

INDU recommended that border/customs officials and the Royal Canadian Mounted Police be provided with appropriate authority to address piracy and counterfeiting, and that border/customs officials be permitted to share information with rights holders regarding suspected goods. For example, the Report notes that ex officio powers for border/customs officials to seize merchandise is standard in other jurisdictions.

INDU also recommended that civil and criminal remedies be introduced for trade-mark counterfeiting. The Report noted the gap between the Trade-marks Act and the Copyright Act with respect to such remedies. While INDU did not recommend specific civil trade-mark remedies, the Report noted the absence of statutory damages under the Trade-marks Act.

To balance a more aggressive approach, INDU recommended that criminal remedies be applied to trade-mark counterfeiting or copyright piracy involving activities which are wilful and on a commercial scale; excessive fines for individuals not acting in this manner would be inappropriate. INDU also suggested that compensation may be needed in cases where seizure is not warranted.

INDU also recommended that the Trade-marks Act be amended to restrict the scope of official marks to important national government symbols and to narrow the definition of public authorities. In this regard, the Report noted that the current official marks provisions have been at times abused by governments in ways that stifle innovation and distort markets.

Industry / Academy / Government Collaboration

INDU recommended that Canada encourage universities to work together to develop template agreements so as to provide greater certainty to businesses entering into partnerships with university researchers. INDU also recommended that government laboratories work together to develop similar template agreements.


While INDU’s Report proposes improvements to Canada’s IP regime, it also highlights ongoing debate about how to use this IP regime to effectively promote innovation in Canada. The Government of Canada will now have to tackle this issue, as INDU has issued a request for government response pursuant to Standing Order 109. The Government will have to present this response within 120 days of INDU’s Report.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions